Development of a Leuckart–Wallach Reaction in Flow for the Synthesis of Abemaciclib-Reference-Cited by-同舟云学术

Development of a Leuckart–Wallach Reaction in Flow for the Synthesis of Abemaciclib

Published:2017-08-29 Issue:9 Volume:21 Page:1447-1451
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Frederick Michael O.^ORCID,Pietz Mark A.,Kjell Douglas P.,Richey Rachel N.,Tharp Gregg A.,Touge Taichiro¹,Yokoyama Naota¹,Kida Michio¹,Matsuo Toshiyasu¹

Affiliation:

1. Corporate Research and Development Devision, Takasago International Corporation, 1-4-11 Nishiyawata, Hiratsuka City, Kanagawa 254-0073, Japan

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.oprd.7b00234

Reference34 articles.

1. http://www.prnewswire.com/news-releases/lilly-announces-phase-3-monarch-2-breast-cancer-study-of-abemaciclib-met-primary-endpoint-of-progression-free-survival-300425928.html(accessed May 9, 2017) .

2. A synthesis of abemaciclib utilizing a Leuckart–Wallach reaction

3. Rational Development of Practical Catalysts for Aromatic Carbon−Nitrogen Bond Formation

4. Carbon−Heteroatom Bond-Forming Reductive Eliminations of Amines, Ethers, and Sulfides

5. Ueber Synthesen in der Biphenylreihe

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous Flow Chemistry: A Novel Technology for the Synthesis of Marine Drugs;Marine Drugs;2023-07-13

2. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022;International Journal of Molecular Sciences;2023-04-23

3. A Brief Review: Advancement in the Synthesis of Amine through the Leuckart Reaction;Reactions;2023-01-29

4. Pyridine ring as an important scaffold in anticancer drugs;Recent Developments in the Synthesis and Applications of Pyridines;2023

5. A simplified, green synthesis of tertiary amines using the Leuckart-Wallach reaction in subcritical water;Tetrahedron Letters;2022-09